Experimental Approaches for the Treatment of Infectious Disease
Monday April 06, 2020
8:00 am
-
10:00 am
Eastern Time (ET)
Room 15 A
DDD
TCP
Chair :
Ericka Anderson
University of California, San Diego
Ross Corriden
Merck
The persistent rise in antibiotic resistance poses a great challenge to public health. Numerous factors, including economic pressures, have created an "innovation gap" in the development of new antibiotics. In addition, frequent use of antibiotics for self-resolving issues, physician reliance on unnecessarily broad-spectrum regimes, widespread use of antibiotics in agricultural feed for growth promotion, and pure Darwinian evolution of bacteria have created a situation where new anti-infective approaches are urgently needed. This symposium highlights translational research efforts underway in academia and industry aimed at resolving this critical unmet medical need.
Speakers
Leonard Dragone
- Janssen
Challenges and Opportunities in Infectious Disease Drug Discovery
Deborah Hung
- Harvard University, Massachusetts General Hospital, Broad Institute of MIT & Harvard
Use of Chemical Genetics to Identify New Approaches for Infectious Disease Intervention
Lynette Cegelski
- Stanford University
Use of Chemical and Structural Microbiology Approaches to Develop New Strategies for Treatment of Antibiotic-resistant Infections
Liangfang Zhang
- University of California, San Diego
Development of Biomimetic Nanotechnologies to Combat Infectious Disease
Ronik Khachatoorian
- University of California, Los Angeles
Structure Activity Relationship Optimization of a 1,3-Disubstituted Urea-based Inhibitor of Zika Virus Infection